SynchroMed EL models 8626 and 8627 and SynchroMed II model 8637 implantable drug pumps


  • Manufacturer Address
    Enquiries to the manufacturer should be addressed to:Dr David Dunham Regulatory Affairs Manager – UK & Ireland Medtronic Limited Suite One Sherbourne House Croxley Green Business Park Watford WD18 8WW Tel: 01923 212213 Fax: 01923 241004E-mail:
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source